Actively Recruiting
Qatar Cardiometabolic Registry
Led by Hamad Medical Corporation · Updated on 2018-01-09
50000
Participants Needed
1
Research Sites
537 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) are closely related. T2DM risk equivalent for CVD and it remains the major cause of death in T2DM. Thus, patients with T2DM and CVD disease are at very high-risk of CVD-related mortality. Therefore, more aggressive metabolic and hemodynamic control is required in such patients to improve the prognosis. We recently initiated a cardio-metabolic clinical service at the Heart Hospital, where T2DM patients with existing CVD are simultaneously examined by Cardiologist and Diabetologist for optimal metabolic and hemodynamic control. We would like to start a clinical registry for all patients who attend this clinical service to collect import clinical data about this population. This registry will serve an important source for future clinical research in the field.
CONDITIONS
Official Title
Qatar Cardiometabolic Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with type 2 diabetes mellitus
- Newly diagnosed heart disease, such as ischemic heart disease, heart failure
You will not qualify if you...
- Patients who do not have type 2 diabetes mellitus
- Preexisting heart disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hamad Medical Coorporation
Doha, Qatar, 3050
Actively Recruiting
Research Team
J
Jassim Al-Suwaidi, MD
CONTACT
R
Rajvir Singh, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here